Tempus AI, Inc. is rated a Buy supporting a robust growth runway and strong 2026 guidance metrics. Learn more about TEM stock ...

The data provider's artificial intelligence-driven solutions are accelerating drug discovery.

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Morgan Stanley Technology, ...

TEM has surged 105% in a year on AI-driven growth, FDA clearances and improving margins, but GAAP losses still cloud the ...

Tempus’ 2025 Total Contract Value (TCV) exceeded $1.1 billion. ・The 2025 agreement roster includes global pharma companies ...

Following the acquisition of Paige in 2025, Tempus launches its new AI-powered, biomarker prediction solution for digital ...

Tempus and Northwestern Medicine will collaborate on ways to use artificial intelligence in clinical care, starting with patients of the Bluhm Cardiovascular Institute. Northwestern Medicine is ...

Chicago artificial intelligence giant Tempus AI is showing it's operating in the black after 10 years and growing.

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration to develop a ...

Chicago, IL – April 25, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and ...

Tempus AI Inc (NASDAQ:TEM) shares are trading higher Tuesday after former House Speaker Nancy Pelosi disclosed a new position in the technology company. What Happened: Pelosi disclosed in a new filing ...

Chicago, IL – January 8, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks ...